Tools

LEADER 01764cam 2200433Ia 4500

001 ocn320266421;

003 OCoLC;

005 20091224122232.0;

006 m d f ;

007 cr a||||||||||;

008 090505s2007 mdu ob f000 0 eng d;

040 a| GPOc| GPOd| GPOd| MvI;

043 a| n-us---;

049 a| ERE#;

074 a| 0499-T-02 (online);

086 0 a| HE 20.4802:D 8/4DRAFT;

245 00 a| Guidance for industry :b| drug-induced liver injury, premarketing clinical evaluation.;

246 30 a| Drug-induced liver injury, premarketing clinical evaluation;

260 a| Rockville, MD :b| U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research :b| Center for Biologics Evaluation and Research,c| [2007];

300 a| 23 p. :b| digital, PDF file;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| Title from PDF title page (viewed on May 5, 2009).;

500 a| "Draft guidance".;

500 a| "Drug safety".;

500 a| "October 2007".;

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references (p. 17-20).;

650 0 a| Liverx| Failure.=| ^A999784;

650 0 a| Drugsx| Side effects.=| ^A1404;

650 0 a| Drugsx| Testing.=| ^A4660;

710 2 a| Center for Drug Evaluation and Research (U.S.)=| ^A431016;

710 2 a| Center for Biologics Evaluation and Research (U.S.)=| ^A368272;

856 40 u| https://purl.fdlp.gov/GPO/LPS112256;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 1898846;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 1898846-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 9/14/2009x| EDOCUMENTz| JERESOURCEo| .STAFF. jlhb;

Guidance for industry : drug-induced liver injury, premarketing clinical evaluation.

Other author	Center for Drug Evaluation and Research (U.S.)
Other author	Center for Biologics Evaluation and Research (U.S.)
Format	Electronic
Publication Info	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [2007]
Description	23 p. : digital, PDF file
Supplemental Content	https://purl.fdlp.gov/GPO/LPS112256
Subjects	Liver--Failure. Drugs--Side effects. Drugs--Testing.

Portion of title	Drug-induced liver injury, premarketing clinical evaluation
General note	Title from PDF title page (viewed on May 5, 2009).
General note	"Draft guidance".
General note	"Drug safety".
General note	"October 2007".
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references (p. 17-20).
GPO item number	0499-T-02 (online)
Govt. docs number	HE 20.4802:D 8/4DRAFT

Guidance for industry : drug-induced liver injury, premarketing clinical evaluation.

Click here for more information about this title